Atara Biotherapeutics Inc at HC Wainwright Cell Therapy Virtual Conference Transcript

Feb 28, 2023 / 08:00PM GMT
Robert Burns - H.C. Wainwright & Co., LLC - Managing Director, Biotech Equity Research

Thank you for joining our next fireside chat. I'm Robert Burns, the Managing Director and Senior Biotech Analyst at H.C. Wainwright. And I'm joined by Pascal Touchon, the President and CEO of Atara Biotherapeutics. Pascal, thank you for joining us today.

Pascal Touchon - Atara Biotherapeutics - President and Chief Executive Officer

Thank you, Robert. Pleasure to be with you today.

Robert Burns - H.C. Wainwright & Co., LLC - Managing Director, Biotech Equity Research

So for those who may be unfamiliar with the Atara story, can you provide a brief high-level overview of the company's platform and pipeline?

Pascal Touchon - Atara Biotherapeutics - President and Chief Executive Officer

Yes, certainly. So Atara is a company based in California with about 330, 350 staff, and we are a leader in the field of allogeneic T-cell therapy for cancer and (inaudible). In fact, what we're doing at

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot